Neoplasm by Cause — Trials

Neoplasm by Cause — Trials · CancerIndex

Clinical trials

Registered studies

708 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 279 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04929028	Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer	active not recruiting	Phase 2	40	National Cancer Institute (NCI)NIH	1	Jun 17, 2026	clinicaltrials
NCT04214249	BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia	active not recruiting	Phase 2	49	National Cancer Institute (NCI)NIH